These contradictory results led to us suggesting that GH administration during somatopause does not produce clearly favorable effects on the endothelial dysfunction, while combined treatments with GH plus IGF-I may produce more beneficial effects on the vascular wall in elderly individuals [125]; however, we do not think that this combination is advisable. This evidence concerns the gene IGF1 and endothelial dysfunction.